Investigator
Guilin Medical University, College of Pharmacy
A novel chiral oxazoline copper(ii)-based complex inhibits ovarian cancer growthin vitroandin vivoby regulating VEGF/VEGFR2 downstream signaling pathways and apoptosis factors
An oxazoline-coordinated copper complex regulates the VEGF/VEGFR2 signaling pathway and apoptosis-related factors to resist ovarian cancerin vivoandin vitro.
Researcher
Guilin Medical University · College of Pharmacy
